Sioux Lookout

Researchers are evaluating the scale-up of point-of-care hepatitis C testing and treatment in Canada, focusing on key populations who face significant barriers to diagnosis and care. Hepatitis C is a major public health concern, especially among people who inject drugs and those in prison. The current multi-step testing process causes delays and loss to follow-up, limiting treatment uptake. This study aims to map clinical processes, identify obstacles and supports, and design tools to help implement point-of-care testing effectively across various settings. The study explores the pre-implementation phase of point-of-care hepatitis C antibody and RNA testing, which provide rapid results within minutes. These tests could enable diagnosis and treatment in a single visit, improving access and reducing dropouts. The research involves analyzing existing care models and working with stakeholders to develop practical strategies, such as training guides and standard procedures, to support widespread adoption. This observational study does not directly implement the tests but focuses on understanding factors that affect their integration and sustainability. Participants include individuals aged 18 or older at risk for hepatitis C, service providers, managers, policymakers, and laboratory or quality assurance staff involved in hepatitis C care. The study collects data on barriers and facilitators based on implementation science frameworks, surveys on acceptability and feasibility of testing strategies, and cost assessments over one year. Researchers will evaluate clinical processes, stakeholder perspectives, and economic factors to inform future efforts to expand point-of-care hepatitis C testing and treatment in Canada.